Coloplast Medical Device Company Intelligence Report

Date: May 31, 2012
Pages: 32
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: C89989BEAE3EN
Leaflet:

Download PDF Leaflet

Coloplast Medical Device Company Intelligence Report
Coloplast develops and manufactures ostomy devices, urology products, continence care devices, advanced wound care and skin care products, as follows:
  • Ostomy Care includes products for people whose intestinal outlet has been surgically-rerouted through the abdominal wall. The company’s key brands within this field include SenSura, Assura, Easiflex, Alterna and Corsinel;
  • Urology, including products for people suffering from diseases of, and damage to, the kidneys, the urinary system or the male reproductive system. Key brands include Minitape, Restorelle, Dormia, Titan, KiWee, Aris, Novasilk, Elefant, Virtue, Altis, Suspend, Exair and Axis;
  • Continence Care for people suffering from diseases of, and damage to, the urinary system. Key brands include SpeediCath, EasiCath, SelfCath, Simplax, Aquadry, Conveen, SpeediBag and Peristeen; and
  • Wound and Skin Care products include dressings for the treatment of chronic wounds and skin care products for prevention and treatment. Key brands include Biatain, Alione, Comfeel, Physiotulle, SeaSorb, Sween, Critic-Aid and InterDry
In June 2006, Coloplast purchased Mentor’s urology unit, which enabled it to expand its existing continence care portfolio and gain new products that address general and surgical urology. This acquisition also moved Coloplast to the leading position in the urology and continence care market segments in which it participates. Through the acquisition, Coloplast also gained Mills Biopharmaceuticals, Mentor’s brachytherapy division, but it sold this business to Core Oncology in June 2007.

In April 2007, Coloplast sold its Breast Care unit, which manufactured external breast forms and post-mastectomy lingerie and swimwear, as part of its strategy to focus on its Ostomy, Urology, Continence, and Wound and Skin Care units.

To further enhance its urology portfolio, Coloplast acquired assets related to the Levera Male Incontinence Therapy - a sling therapy designed to address symptoms of male stress urinary incontinence (SUI) - from Caldera Medical in November 2007.

More recently, Coloplast expanded its urology portfolio and expanded its geographic coverage in the US with the acquisition of Mpathy Medical Devices, a developer of less invasive surgical solutions for the treatment of female stress urinary incontinence and pelvic organ prolapse.

In March 2011, Coloplast completed the transfer of the majority of production from Denmark to lower-cost Hungary and China. Approximately 85% of the company’s products are now produced in Hungary and China.

Coloplast markets and sells its products and services globally. The majority of its revenue is generated in Europe, which accounted for 73% of the company’s DKr10,172 million of total sales in fiscal 2011. At the end of September 2011, Coloplast employed more than 7,350 people.

Coloplast’s major shareholders are members of the Louis-Hansen family, which hold approximately 31% of the share capital and 55% of the votes in Coloplast.

This company report provides
  • Overview
    • Key contact information
    • Introduction to the company and its current activities
    • Summary of its financial performance
    • Who are the company’s major competitors?
    • Key recent events in an “at a glance” format
  • Financial Review
    • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
    • Table providing in-depth five-year financial analysis
    • Employee data, including breakdown by company division and geographic location
  • Strategic Focus
    Investigates the company’s aims and its areas of focus
  • Products
    Core product areas, key brands, product approvals and launches Research and Development
    • How much has been invested in R&D?
    • Where is the research based?
    • What alliances and agreements does the company have and with whom?
  • Manufacturing and Distribution
    • Identifying the company’s manufacturing locations
    • Sales and marketing facilities
  • Agreements
    • With whom has the company reached agreements and what do they involve?
    • Key contracts awarded
  • Mergers, Acquisitions, Minority Investments and Divestments
  • Litigation
  • Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

First Half Fiscal Year 2012 Financial Results
Fiscal Year 2011 Financial Results
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

PRODUCTS

Ostomy Care
  Closed Bags
    Closed Bag Product Types
  Drainable Bags
     Drainable Bag Product Types
   Urostomy Bags
     Urostomy Bag Product Types
   Paediatric Ostomy
  Hernia Support
  Ostomy Accessories
  Ostomy Market
Continence Care
  Catheters
  Urine Bags
  Urisheaths
  Bowel Management
  Continence Market
Urology Care
   Urology Market
Wound and Skin Care
  Wound Care
    Dressings
     Hydrogels
   Fistula & Wound Management System
   Wound Care Market
   Skin Care

RESEARCH AND DEVELOPMENT

R&D Expenditure
R&D Facilities
R&D Studies
  Altis Single Incision Sling System for Female Stress Urinary Incontinence Study
Global DialogueStudy

MANUFACTURING

AGREEMENTS

Smith & Nephew
Johnson & Johnson
Caldera Medical
Carbon Medical Technologies
Tutogen Medical (now RTI Biologics)
Rochester Medical
McKesson

MERGERS AND ACQUISITIONS

Mpathy Medical Devices and Gyne Ideas
Caldera Medical Assets
Mentor’s Urology Division
Amoena
SSL International’s Continence Care Business
Home Supply & Care
Co-Inject
Sween

MINORITY INVESTMENTS

IctalCare and CutiSense
Acarix
Interface Biotech
Nordic Vaccine Technology

DIVESTITURES

Mills Biopharmaceuticals
Breast Care Division
Sterling Medical Services
Contrelle
Aviana Brand
Consumer Products Division
HSC’s Nutrition Business

LITIGATION

Generic Medical Devices

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Coloplast - First Half Fiscal Year 2012 Financial Results
Coloplast - First Half Fiscal Year 2012 Revenues by Business Segment
Coloplast - First Half Fiscal Year 2012 Revenues by Geographic Area
Coloplast - Annual Financial Results, Fiscal Years 2007-2011
Coloplast - Annual Revenues by Business Segment, Fiscal Years 2007-2011
Coloplast - Annual Revenues by Geographic Area, Fiscal Years 2007-2011
Coloplast – Five-Year Financial Summary
Coloplast - Employees
Coloplast – Annual R&D Expenses
Coloplast – Manufacturing Facilities, April 2012
Agreements Summary
Mergers and Acquisitions Summary
Coloplast - Key Corporate Events

LIST OF CHARTS

Coloplast - Annual Sales and Operating Income, Fiscal Years 2007-2011
Coloplast - Annual Sales by Business Segment, Fiscal Years 2010-2011
Coloplast - Annual Revenues by Geographic Area, Fiscal Years 2007-2011
Coloplast – Fiscal 2011 Sales by Business Area
Coloplast - Transfer of Production
Skip to top


ConvaTec Medical Device Company Intelligence Report US$ 515.00 Mar, 2012 · 34 pages
Fresenius Medical Device Company Intelligence Report US$ 515.00 Apr, 2013 · 42 pages
Nipro Medical Device Company Intelligence Report US$ 515.00 Apr, 2013 · 26 pages
Smith Medical Device Company Intelligence Report US$ 515.00 Mar, 2013 · 40 pages
Teleflex Medical Device Company Intelligence Report US$ 515.00 May, 2012 · 34 pages

Ask Your Question

Coloplast Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: